Skip to main content

Table 6 Patients with increased CRP and normal albumin level had a better median progression free survival and median overall survival than patients with normal CRP and decreased albumin level in the patients with GPS 1 (not statistically significant)

From: Prognostic significance of a systemic inflammatory response in patients receiving first-line palliative chemotherapy for recurred or metastatic gastric cancer

  Patients with increased CRP and normal albumin level (n= 87) Patients with normal CRP and decreased albumin level (n= 24) P-value
mPFS (months) 3.433 2.533 0.489
  (95% CI 2.648-4.219) (95% CI 0.000-5.284)  
mOS (months) 8.9 8.7 0.915
  (95% CI 7.003-10.930) (95% CI 5.779-11.621)  
  1. mPFS: median progression free survival, mOS: median overall survival, CRP: C-reactive protein